Literature DB >> 2942549

Androgen receptors in experimentally induced colon carcinogenesis.

J R Izbicki, G Wambach, S R Hamilton, E Harnisch, R Hogenschurz, W Izbicki, J Kusche.   

Abstract

Sex hormones may play a role in colonic carcinogenesis, as evidenced by epidemiologic and experimental data showing different tumor rates in males and females. We investigated the effects of hormonal manipulation on tumor development and on androgen receptor binding in both colonic wall and experimentally induced tumors in male rats. Five of six groups, each with 40 animals, were given 10 weekly s.c. injections of azoxymethane (AOM), 7.5 mg/kg body weight. Group-I served as normal controls. Group-II received AOM only. Group-III was castrated 2 weeks prior to carcinogen treatment. Group-IV was castrated similarly and then hormone substituted with testosterone propionate. Group-V was chemically castrated with the anti androgen cyproterone acetate. Group-VI was castrated and given hormone vehicle. Scatchard analysis for androgen receptors in cytosol from normal colonic wall and tumor was performed with 3H-methyltrienolone as the ligand. Androgens were found to have an inhibitory effect on carcinogenesis: chemical castration increased colonic tumor development (P less than 0.05 for multiplicity), and testosterone administration produced a borderline statistically significant reduction in tumor incidence in surgically castrated rats (P less than 0.053), particularly in the right colon. Specific binding sites for androgen with high affinity and low capacity were found in the colonic wall of all groups. Receptor density was not altered by AOM administration, but increased after surgical castration. Receptor density was markedly lower in tumors than in normal colonic wall. Receptor binding sites in tumors were not altered by the various hormonal manipulations. Our study demonstrated that although cytoplasmic androgen receptors are present in colonic wall and in experimental tumors, AOM-induced colonic carcinogenesis appears to be only mildly affected by manipulation of androgens.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2942549     DOI: 10.1007/bf00394937

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  32 in total

1.  Some prognostic factors in survival of patients with cancer of the colon and rectum.

Authors:  J D Godwin; C C Brown
Journal:  J Chronic Dis       Date:  1975-10

Review 2.  Experimental colon cancer.

Authors:  J T LaMont; T A O'Gorman
Journal:  Gastroenterology       Date:  1978-12       Impact factor: 22.682

3.  Genetic factors in families with combined gastrointestinal and breast cancer.

Authors:  H T Lynch; A J Krush; H Guirgis
Journal:  Am J Gastroenterol       Date:  1973-01       Impact factor: 10.864

4.  Cancer of the colon and rectum and adenomatous polyps. A review of epidemiologic findings.

Authors:  W Haenszel; P Correa
Journal:  Cancer       Date:  1971-07       Impact factor: 6.860

5.  Estrogen and progestin receptors in colonic cancer?

Authors:  T Wobbes; L V Beex; A M Koenders
Journal:  Dis Colon Rectum       Date:  1984-09       Impact factor: 4.585

6.  Large bowel cancer in women in relation to reproductive and hormonal factors: a case-control study.

Authors:  J D Potter; A J McMichael
Journal:  J Natl Cancer Inst       Date:  1983-10       Impact factor: 13.506

7.  Colonic neoplasms: tissue estrogen receptor and carcinoembryonic antigen.

Authors:  J E McClendon; D Appleby; D B Claudon; W L Donegan; J J DeCosse
Journal:  Arch Surg       Date:  1977-03

8.  Steroid hormone receptors in dimethylhydrazine-induced rat colonic tumors.

Authors:  M Krelenbaum; A M Kareem; D Fleiszer; A G Fazekas
Journal:  Anticancer Res       Date:  1984 Nov-Dec       Impact factor: 2.480

9.  Effects of steroid hormone therapy on primarily xenotransplanted human colorectal adenocarcinomas.

Authors:  J R Izbicki; R Schmitz; H O Hoppen; W Izbicki; H Troidl
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

10.  Steroid receptors and the distribution of IR-carcinoembryonic antigen in colonic cancer.

Authors:  E Odagiri; K Jibiki; R Demura; H Shinozaki; S Nakamura; H Demura; H Suzuki
Journal:  Dis Colon Rectum       Date:  1984-12       Impact factor: 4.585

View more
  5 in total

1.  Sex disparity in colonic adenomagenesis involves promotion by male hormones, not protection by female hormones.

Authors:  James M Amos-Landgraf; Jarom Heijmans; Mattheus C B Wielenga; Elisa Dunkin; Kathy J Krentz; Linda Clipson; Antwan G Ederveen; Patrick G Groothuis; Sietse Mosselman; Vanesa Muncan; Daniel W Hommes; Alexandra Shedlovsky; William F Dove; Gijs R van den Brink
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-03       Impact factor: 11.205

2.  Effect of steroid hormones on human colorectal adenocarcinoma xenografts, of known steroid-receptor status, in nude mice.

Authors:  W S Stebbings; G P Vinson; M J Farthing; F Balkwill; R F Wood
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

Review 3.  The role of testosterone in colorectal carcinoma: pathomechanisms and open questions.

Authors:  Mohsin H K Roshan; Amos Tambo; Nikolai P Pace
Journal:  EPMA J       Date:  2016-11-10       Impact factor: 6.543

Review 4.  Role of anabolic agents in colorectal carcinogenesis: Myths and realities (Review).

Authors:  Theodore Krasanakis; Taxiarchis Konstantinos Nikolouzakis; Markos Sgantzos; Theodore Mariolis-Sapsakos; John Souglakos; Demetrios A Spandidos; Christina Tsitsimpikou; Aristidis Tsatsakis; John Tsiaoussis
Journal:  Oncol Rep       Date:  2019-10-03       Impact factor: 3.906

5.  Clinicopathological and prognostic significance of androgen receptor overexpression in colorectal cancer. Experience from Al-Madinah Al-Munawarah, Saudi Arabia.

Authors:  Abdulkader M Albasri; Mohammed A Elkablawy
Journal:  Saudi Med J       Date:  2019-09       Impact factor: 1.484

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.